Regeneron Pharmaceuticals Inc.
History
| Year | Detail |
|---|---|
| 1988 | Regeneron was founded. |
| 1990 | Announced a collaboration to develop neurotrophic factors. |
| 1992 | Clinical development of investigational drug, a neurotrophic factor, begins. |
| 2000 | Investigational medicine rilonacept begins clinical exploration. |
| 2004 | Investigational medicine aflibercept begins clinical development. |
| 2006 | Entered a collaboration with Bayer HealthCare. |
| 2007 | The company collaborated with Sanofi. |
| 2008 | The FDA approved first medicine, ARCALYST Injection. |
| 2013 | European business office opens in Dublin, Ireland. |
| 2015 | Launched a major new immuno-oncology collaboration with Sanofi. |
| 2022 | The company acquried Checkmate Pharmaceuticals. |
BCC Research Beacon 